RARE
Ultragenyx Pharmaceutical
$16.08
+$0.43 (+2.75%)Oct 26, 2026
Key metrics
The numbers that frame RARE today
- Market cap
- $1.59B
- Gross margin
- 83.1%
- EV / Sales
- 3.7
- ROIC
- -35.3%
- Div yield
- 0%
- 52wk Low
- $12.73
- 52wk High
- $39.89
Growth
Revenue and earnings trend for RARE
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about RARE
Is Ultragenyx Pharmaceutical a good buy?
Yes. Ultragenyx Pharmaceutical has strong quality, and it outweighs the poor momentum here. Growth looks excellent, which supports the long-term business case. We think Ultragenyx Pharmaceutical is selling at a very high price, which cuts against the buy case.
What is the market capitalization of RARE?
Ultragenyx Pharmaceutical's market capitalization is $1.59B.
What is the 52-week high for RARE stock?
The 52-week high for Ultragenyx Pharmaceutical is $39.89. The current close of $16.08 is 59.7% below that high.
What is the 52-week low for RARE stock?
The 52-week low for Ultragenyx Pharmaceutical is $12.73. The current close of $16.08 is 26.3% above that low.
Does RARE stock pay dividends?
Ultragenyx Pharmaceutical does not currently show a dividend per share in the company data.